(Q39247659)

English

Cross-talk between glycogen synthase kinase 3β (GSK3β) and p38MAPK regulates myocyte enhancer factor 2 (MEF2) activity in skeletal and cardiac muscle

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Cross-talk between glycogen synthase kinase 3β (GSK3β) and p38MAPK regulates myocyte enhancer factor 2 (MEF2) activity in skeletal and cardiac muscle (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

author name string

M G Dionyssiou

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

N B Nowacki

2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

S Hashemi

3

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

J Zhao

4

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

A Kerr

5

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

R G Tsushima

6

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

J C McDermott

7

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

publication date

5 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Journal of Molecular and Cellular Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

35-44

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

MAP kinases and cell migration

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Requirement for p38alpha in erythropoietin expression: a role for stress kinases in erythropoiesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

p38 mitogen-activated protein kinase activity commits embryonic stem cells to either neurogenesis or cardiomyogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

MAP kinase signalling pathways in cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Phosphorylation motifs regulating the stability and function of myocyte enhancer factor 2A

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Human SRF-related proteins: DNA-binding properties and potential regulatory targets

2 references

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

based on heuristic

inferred from DOI database lookup

MEF2: a central regulator of diverse developmental programs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Phosphorylation and alternative pre-mRNA splicing converge to regulate myocyte enhancer factor 2C activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Alternative pre-mRNA splicing governs expression of a conserved acidic transactivation domain in myocyte enhancer factor 2 factors of striated muscle and brain.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Differentiation-dependent lysine 4 acetylation enhances MEF2C binding to DNA in skeletal muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Association with class IIa histone deacetylases upregulates the sumoylation of MEF2 transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

A recurrent phospho-sumoyl switch in transcriptional repression and beyond

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Phosphorylation of the MADS-Box transcription factor MEF2C enhances its DNA binding activity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Regulation of vertebrate myotome development by the p38 MAP kinase-MEF2 signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Protein kinase A represses skeletal myogenesis by targeting myocyte enhancer factor 2D.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

The renaissance of GSK3

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

GSK-3: tricks of the trade for a multi-tasking kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Unique and overlapping functions of GSK-3 isoforms in cell differentiation and proliferation and cardiovascular development

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Mitogen-activated protein kinases (Erk1,2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Glycogen synthase kinase 3: more than a namesake

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Protein kinase cascades in the regulation of cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Inhibition of glycogen synthase kinase-3beta activity is sufficient to stimulate myogenic differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Phosphatidylinositol 3-kinase stimulates muscle differentiation by activating p38 mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Functional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

MEKK4 stimulation of p38 and JNK activity is negatively regulated by GSK3beta

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Akt regulates the survival of vascular smooth muscle cells via inhibition of FoxO3a and GSK3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

GSK-3beta negatively regulates skeletal myotube hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Structural insights and biological effects of glycogen synthase kinase 3-specific inhibitor AR-A014418

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Post-translational control of the MEF2A transcriptional regulatory protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

The MEF2D transcription factor mediates stress-dependent cardiac remodeling in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Cardiac hypertrophy: the good, the bad, and the ugly

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

The role of Akt/GSK-3beta signaling in familial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Inhibition of glycogen synthase kinase 3beta prevents peroxide-induced collapse of mitochondrial membrane potential in rat ventricular myocytes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2012.10.013

7 January 2021

Identifiers

10.1016/J.YJMCC.2012.10.013

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39247659&oldid=1815876281"